Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01668563 · ClinicalTrials.gov registry record · NA
International Subarachnoid Aneurysm Trial II
A NA study of Intracranial Hemorrhage Ruptured Aneurysm, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Active
- Registry status
- NA
- Development phase
- 1,724
- Enrollment target
- 6
- Study locations
NCT01668563: Active NA study of Intracranial Hemorrhage Ruptured Aneurysm, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
NCT01668563 is a NA study of Intracranial Hemorrhage Ruptured Aneurysm that is active but no longer recruiting, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 1,724 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% higher). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01668563, a NA study of Intracranial Hemorrhage Ruptured Aneurysm, is active but no longer recruiting, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,724 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to compare the clinical outcome of surgical clipping and endovascular coiling for ruptured intracranial aneurysms not included in the original ISAT Study.
Conditions Studied
Interventions
- PROCEDURE surgical management
- PROCEDURE Endovascular management
Study Locations (6)
Alberta
- Foothills Medical Centre - Calgary
- University of Alberta Hospital - Edmonton
Other
- Vall d'Hebron Hospital - Barcelona
- University of Valladolid - Valladolid
New York
- Montefiore Medical Center - The Bronx
Quebec
- Centre Hospitalier de l'Université de Montréal - Hôpital Notre Dame - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,724 participants |
| Start Date | 2012-11-12 |
| Est. Completion | 2024-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01668563
The ClinicalTrials.gov registry entry for NCT01668563 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,724 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% higher). The listed sponsor is Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracranial Hemorrhage Ruptured Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which surgical management is the first listed.
NCT01668563 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Alberta, Other, New York.
Frequently Asked Questions
What is clinical trial NCT01668563 about?
NCT01668563 is a clinical study titled "International Subarachnoid Aneurysm Trial II". The purpose of this study is to compare the clinical outcome of surgical clipping and endovascular coiling for ruptured intracranial aneurysms not included in the original ISAT Study.
What is the current status of trial NCT01668563?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,724 participants. The study started on 2012-11-12. Estimated completion is 2024-12.
What conditions does trial NCT01668563 study?
This clinical trial studies the following conditions: Intracranial Hemorrhage Ruptured Aneurysm.
What interventions are being tested in trial NCT01668563?
The interventions under investigation include: surgical management (PROCEDURE), Endovascular management (PROCEDURE).
Who is sponsoring clinical trial NCT01668563?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01668563 being conducted?
This trial has 6 study locations across New York, Alberta, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.